Endocyte, Inc. News Headlines

ECYT 
$6.3
*  
0.43
6.39%
Get ECYT Alerts
*Delayed - data as of Mar. 5, 2015 15:10 ET  -  Find a broker to begin trading ECYT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ECYT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Next Week In Biotech: Pacira PDUFA, Geron And Dendreon Report
2/27/2015 9:00:00 AM - Seeking Alpha


What's in Store for Endocyte (ECYT) this Earnings Season? - Analyst Blog
2/20/2015 12:30:00 PM - Zacks.com


Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha


Don't Worry About Orexigen's Obesity Drug EU Approval
2/10/2015 9:34:15 AM - Motley Fool


Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
1/30/2015 4:00:00 PM - Seeking Alpha


Endocyte: Small Company, Small Valuation, Full Pipeline
1/30/2015 1:22:00 PM - Seeking Alpha


Biotech Weekly: Top Value Biotech Picks For 2015
1/5/2015 9:01:00 AM - Seeking Alpha


Why Endocyte (ECYT) Could Be Positioned for a Surge? - Tale of the Tape
11/28/2014 8:43:00 AM - Zacks.com


Endocyte, Inc. (ECYT) in Focus: Stock Surges 18% - Tale of the Tape
11/7/2014 9:18:07 AM - Zacks.com


Will Endocyte (ECYT) Miss This Earnings Season? - Analyst Blog
11/4/2014 4:50:00 PM - Zacks.com


Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog
9/29/2014 4:25:00 PM - Zacks.com


Why Endocyte, Inc. Stock Briefly Spiked Higher
9/29/2014 12:34:11 PM - Motley Fool


Pre-Market Most Active for Sep 29, 2014 : TIBX, ATHL, BABA, PBR, DWA, TVIX, AAPL, ECYT, JNS, SAN, BP, ALIM
9/29/2014 7:39:56 AM - NASDAQ.com News


Strength Seen in Flexion Therapeutics (FLXN): Stock Soars 17.8% - Tale of the Tape
9/11/2014 8:46:00 AM - Zacks.com


Aradigm Corporation (ARDM) Up: Stock Adds 9.7% in Session - Tale of the Tape
9/11/2014 8:32:00 AM - Zacks.com


NASDAQ Biotechnology Top Performers (As Of Market Open September 11)
9/11/2014 7:27:38 AM - David Krein


Endocyte (ECYT) Worth Watching: Stock Soars 17% - Tale of the Tape
9/10/2014 8:46:00 AM - Zacks.com


Zacks Rank #1 Additions for Wednesday - Tale of the Tape
9/10/2014 8:30:00 AM - Zacks.com


Sector Update: Health Care Stocks Outperform Most Sectors; Endocyte Spikes on New BMO Capital Coverage
9/9/2014 3:08:19 PM - MT Newswires


Sector Update: Health Care
9/9/2014 3:01:04 PM - MT Newswires


Endocyte (ECYT) Shares March Higher, Can It Continue? - Tale of the Tape
9/2/2014 7:54:49 AM - Zacks.com


ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog
8/11/2014 11:21:00 AM - Zacks.com


Jazz Pharmaceuticals (JAZZ) Jumps: Stock Moves 5.2% Higher - Tale of the Tape
8/7/2014 8:46:00 AM - Zacks.com


Valeant Pharmaceuticals Slumps: VRX Falls 5.3% in Session - Tale of the Tape
8/6/2014 7:43:00 AM - Zacks.com


Durata Therapeutics (DRTX) Worth Watching: Stock Gains 18.5% - Tale of the Tape
8/5/2014 8:46:00 AM - Zacks.com